[1]
K. Reczka, Z. . Zalewska, J. . Szymkowiak, and M. . Woźniak, “EXPANDING THERAPEUTIC HORIZONS OF GLP-1 RECEPTOR AGONISTS: FROM METABOLIC REGULATION TO NEUROPROTECTION IN ALZHEIMER’S DISEASE AND ADDICTION DISORDERS – A COMPREHENSIVE REVIEW”, IJITSS, vol. 1, no. 4(52), Oct. 2026, doi: 10.31435/ijitss.4(52).2026.6289.